Safety of Intravenously Applied Mistletoe Extract – Results from a Phase I Dose Escalation Study in Patients with Advanced Cancer
BMC Complementary and Alternative Medicine(2017)
摘要
Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited.
更多查看译文
关键词
Viscum album,Intravenous,Cancer,Clinical trial,MTD,Side effects
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要